Somerset Indus Capital Partners 
Dealstreet

ELP advises Somerset Indus Capital Partners in its investment in Natural Biogenex

The investment amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Natural Biogenex Private Limited, a company manufacturing steroidal APIs.

This marks the fund’s sixth overall investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this investment.

The transaction team consisted of Vinay Butani (Partner), Rudraksh Bhatt (Senior Associate) and Faiz Thakur (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

'Swatantryaveer' title of VD Savarkar not conferred by government but appears in his biography: Savarkar's grandnephew tells court

Attending RSS Seminar doesn’t prove bias: CBI in Kejriwal plea for Justice Swarna Kanta Recusal

Delhi court bans news reports linking Manoj Sandesara, family to Sterling Biotech bank fraud case

Operation Sindoor: Punjab & Haryana High Court grants bail to man accused of spying for Pakistan

Delhi court grants bail to Sukesh Chandrasekhar in ED case on AIADMK poll symbol

SCROLL FOR NEXT